Scientific Programs

Our direct research into the causes, treatment, and prevention of cancer, AIDS, and related diseases. From basic research into the molecular mechanisms of carcinogenesis to pre-clinical investigation of potential new treatments, scientists at NCI-Frederick are studying the origins of cancer—the genes, proteins, and signals involved in initiation—and identifying possible targets to treat or prevent the disease.

Programs encompass investigators, organized within a specific field of research, who are working together to solve a complex scientific problem.

AIDS and Cancer Virus Program - Jeffrey D. Lifson, M.D.
Advanced Technology Program (ATP) - Atsuo Kuki, Ph.D.
Biopharmaceutical Development Program - George Mitra, Ph.D.
Cancer and Inflammation Program - Giorgio Trinchieri, M.D.
CCR Nanobiology Program - Robert Blumenthal, Ph.D.
Clinical Monitoring Research Program (CMRP) - Beth Baseler, M.S.
Clinical Services Program - Michael W. Baseler, Ph.D.
Developmental Therapeutics Program - Jerry M. Collins, Ph.D., Associate Director
HIV Drug Resistance Program - Stephen H. Hughes, Ph.D.
Laboratory Animal Sciences Program - Lionel Feigenbaum, Ph.D.
Mouse Cancer Genetics Program - Lino Tessarollo, Ph.D. (Acting Program Director)